Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation. 


Biotechnology

Xalud Therapeutics

Steve Collins

Howard Rutman

Sarah LeBlanc

Morgan Stokes

Jayson Rieger

Sean Stalfort

Sung You

Paul Manning

Jaspal Singh

Nathaniel Katz

Lee Simon

Leonardo Kapural

Amy S. Chappell

Matt Walker

Eric Grigsby

Mace Rothenberg

Linda Watkins

Michael Ehlers

Tarek Samad

The Strategic Advisory Team at Xalud Therapeutics provides expert guidance on long-term planning, market positioning, and partnership opportunities to optimize the development and commercialization of the company's non-viral gene therapy platform. Their collective expertise helps navigate regulatory landscapes, investment strategies, and scientific advancements to drive Xalud's mission forward.

Strategic Advisory Team

The Clinical and Medical Operations team at Xalud Therapeutics is responsible for overseeing the design, implementation, and management of clinical trials to advance the company’s non-viral gene therapy treatments for pathologic inflammation. This team ensures compliance with regulatory standards, optimizes trial logistics, and collaborates closely with medical experts to drive therapeutic innovations from concept to clinical application.

Clinical and Medical Operations

Xalud Therapeutics

Org chart

Board & advisors

Teams

Strategic Advisory Team

Clinical and Medical Operations

Offices

Xalud Therapeutics

Org chart

Board & advisors

Teams

Strategic Advisory Team

Clinical and Medical Operations

Offices

Related companies